Your browser doesn't support javascript.
loading
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML.
DiNardo, C D; Tiong, I S; Quaglieri, A; MacRaild, S; Loghavi, S; Brown, F C; Thijssen, R; Pomilio, G; Ivey, A; Salmon, J M; Glytsou, C; Fleming, S A; Zhang, Q; Ma, H; Patel, K P; Kornblau, S M; Xu, Z; Chua, C C; Chen, Xufeng; Blombery, P; Flensburg, C; Cummings, N; Aifantis, I; Kantarjian, H; Huang, D C S; Roberts, A W; Majewski, I J; Konopleva, M; Wei, A H.
Affiliation
  • DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Tiong IS; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia.
  • Quaglieri A; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
  • MacRaild S; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Loghavi S; Department of Medical Biology and.
  • Brown FC; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia.
  • Thijssen R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pomilio G; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
  • Ivey A; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Salmon JM; Department of Medical Biology and.
  • Glytsou C; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
  • Fleming SA; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia.
  • Zhang Q; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
  • Ma H; Department of Pathology and Perlmutter Cancer Center, NYU School of Medicine, New York, NY.
  • Patel KP; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia.
  • Kornblau SM; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
  • Xu Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Chua CC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Chen X; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Blombery P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Flensburg C; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Cummings N; Department of Medical Biology and.
  • Aifantis I; Department of Haematology, The Alfred Hospital, Melbourne, VIC, Australia.
  • Kantarjian H; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
  • Huang DCS; Department of Pathology and Perlmutter Cancer Center, NYU School of Medicine, New York, NY.
  • Roberts AW; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
  • Majewski IJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; and.
  • Konopleva M; Department of Haematology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Wei AH; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
Blood ; 135(11): 791-803, 2020 03 12.
Article in En | MEDLINE | ID: mdl-31932844
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Blood Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Blood Year: 2020 Type: Article